BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 19086766)

  • 1. Nonhuman primate neuroimaging and cocaine medication development.
    Howell LL
    Exp Clin Psychopharmacol; 2008 Dec; 16(6):446-57. PubMed ID: 19086766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys.
    Howell LL; Carroll FI; Votaw JR; Goodman MM; Kimmel HL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):757-65. PubMed ID: 17105829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
    Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates.
    Howell LL; Wilcox KM
    J Pharmacol Exp Ther; 2001 Jul; 298(1):1-6. PubMed ID: 11408518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys.
    Wilcox KM; Lindsey KP; Votaw JR; Goodman MM; Martarello L; Carroll FI; Howell LL
    Synapse; 2002 Jan; 43(1):78-85. PubMed ID: 11746736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.
    Hiranita T; Soto PL; Kohut SJ; Kopajtic T; Cao J; Newman AH; Tanda G; Katz JL
    J Pharmacol Exp Ther; 2011 Nov; 339(2):662-77. PubMed ID: 21859929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys.
    Wilcox KM; Kimmel HL; Lindsey KP; Votaw JR; Goodman MM; Howell LL
    Synapse; 2005 Dec; 58(4):220-8. PubMed ID: 16206183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous measurement of extracellular dopamine and dopamine transporter occupancy by cocaine analogs in squirrel monkeys.
    Kimmel HL; Nye JA; Voll R; Mun J; Stehouwer J; Goodman MM; Votaw JR; Carroll FI; Howell LL
    Synapse; 2012 Jun; 66(6):501-8. PubMed ID: 22237864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.
    Shang Y; Gibbs MA; Marek GJ; Stiger T; Burstein AH; Marek K; Seibyl JP; Rogers JF
    J Clin Psychopharmacol; 2007 Feb; 27(1):71-5. PubMed ID: 17224717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca
    Ruchala I; Battisti UM; Nguyen VT; Chen RY; Glennon RA; Eltit JM
    Toxicol Appl Pharmacol; 2021 May; 419():115513. PubMed ID: 33785354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice.
    Thomsen M; Hall FS; Uhl GR; Caine SB
    J Neurosci; 2009 Jan; 29(4):1087-92. PubMed ID: 19176817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents.
    Cao J; Kulkarni SS; Husbands SM; Bowen WD; Williams W; Kopajtic T; Katz JL; George C; Newman AH
    J Med Chem; 2003 Jun; 46(13):2589-98. PubMed ID: 12801223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
    Ravna AW; Sylte I; Dahl SG
    J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
    Budygin EA; John CE; Mateo Y; Jones SR
    J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTDP-32476: A Promising Agonist Therapy for Treatment of Cocaine Addiction.
    Xi ZX; Song R; Li X; Lu GY; Peng XQ; He Y; Bi GH; Sheng SP; Yang HJ; Zhang H; Li J; Froimowitz M; Gardner EL
    Neuropsychopharmacology; 2017 Feb; 42(3):682-694. PubMed ID: 27534265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional differences in extracellular dopamine and serotonin assessed by in vivo microdialysis in mice lacking dopamine and/or serotonin transporters.
    Shen HW; Hagino Y; Kobayashi H; Shinohara-Tanaka K; Ikeda K; Yamamoto H; Yamamoto T; Lesch KP; Murphy DL; Hall FS; Uhl GR; Sora I
    Neuropsychopharmacology; 2004 Oct; 29(10):1790-9. PubMed ID: 15226739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
    Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
    J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probes for the dopamine transporter: new leads toward a cocaine-abuse therapeutic--A focus on analogues of benztropine and rimcazole.
    Newman AH; Kulkarni S
    Med Res Rev; 2002 Sep; 22(5):429-64. PubMed ID: 12210554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Novel Modafinil Analog, JJC8-016, as a Potential Cocaine Abuse Pharmacotherapeutic.
    Zhang HY; Bi GH; Yang HJ; He Y; Xue G; Cao J; Tanda G; Gardner EL; Newman AH; Xi ZX
    Neuropsychopharmacology; 2017 Aug; 42(9):1871-1883. PubMed ID: 28266501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.
    Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME
    J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.